The Office of Clinical Trial Activation (OCTA) is excited to announce that James Sulahian has accepted the role of OnCore Manager effective January 14, 2024.

James has been serving as the Interim OnCore Manager since September 2023. He first joined OCTA as a Clinical Research Management Analyst in 2021 and has nearly two decades of experience in clinical research systems and operations. James has demonstrated his commitment to the role by helping to expand the OnCore Financials program and ensuring quality and support operations. Prior to joining UCSF, he worked as a CTMS Supervisor at UC Irvine and as an Informatics Program Manager at Chao Family Comprehensive Cancer Center. James possesses invaluable expertise in designing and implementing research-related tools and workflows for academic medical centers. 

Please join OCTA in congratulating James on his promotion!